Characterization of diverse targetable alterations in ERBB2 and ERBB3 in 93,465 non-small cell lung cancers (NSCLC)

Liu, DZ; Keller, RB; Heilmann, AM; Allen, J; Oxnard, GR; Bazhenova, L; Schrock, AB; Li, BT

JOURNAL OF CLINICAL ONCOLOGY, 2023; 41 (16):